Autolus Therapeutics (AUTL) Capital Expenditures Growth (1y) (2019 - 2025)
Autolus Therapeutics (AUTL) Capital Expenditures Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,071.81 Bn | - | 38.18% |
| 2 | Nanobiotix | 1,925.70 Bn | 1,925.64 Bn | - | - |
| 3 | Akari Therapeutics | 1,062.88 Bn | 1,062.88 Bn | - | - |
| 4 | BeOne Medicines | 469.09 Bn | 464.29 Bn | 1.35 Bn | -27.93% |
| 5 | Vertex Pharmaceuticals | 123.09 Bn | 115.84 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 70.32 Bn | 61.57 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 63.36 Bn | 63.36 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.71 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.69 Bn | 34.68 Bn | 959.66 Mn | 143.40% |
| 10 | Autolus Therapeutics | 395.22 Mn | 94.51 Mn | -1.04 Mn | -107.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -107.96% |
| Sep 30, 2025 | -54.03% |
| Jun 30, 2025 | 788.52% |
| Mar 31, 2025 | 1,385.23% |
| Dec 31, 2024 | 652.34% |
| Sep 30, 2024 | 540.12% |
| Jun 30, 2024 | -81.04% |
| Mar 31, 2024 | -84.97% |
| Dec 31, 2023 | 133.33% |
| Sep 30, 2023 | -71.70% |
| Jun 30, 2023 | 4.22% |
| Mar 31, 2023 | 378.86% |
| Dec 31, 2022 | -60.06% |
| Sep 30, 2022 | 37.09% |
| Jun 30, 2022 | 174.26% |
| Mar 31, 2022 | -59.42% |
| Dec 31, 2021 | -71.03% |
| Sep 30, 2021 | -4.64% |
| Jun 30, 2021 | 181.90% |
| Mar 31, 2021 | -58.91% |